References
- Han JJ, Beltran TH, Song JW, et al. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men. JAMA Oncol.. 2017;3(6):810–816. doi:10.1001/jamaoncol.2016.6192.
- Thompson EL, Vamos CA, Vázquez-Otero C, et al. Trends and predictors of HPV vaccination among U.S. College women and men. Prevent Med. 2016; 86:92–98. doi:10.1016/j.ypmed.2016.02.003.
- Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 2017;123(12):2219–2229. doi:10.1002/cncr.30588.
- Nandwani MC. Men's knowledge of the human papillomavirus vaccine. Nurse Pract. 2010;35(11):32–39. doi:10.1097/01.NPR.0000388900.49604.e1.
- Lowy DR, Solomon D, Hildesheim A, et al. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer. 2008;113(7 suppl):1980–1993., doi:10.1002/cncr.23704.
- Chatterjee A. The next generation of HPV vaccines: Nonavalent vaccine V503 on the horizon. Expert Rev Vaccines. . 2014;13(11):1279–1290. doi:10.1586/14760584.2014.963561.
- Steinbrook R. The Potential of Human Papillomavirus Vaccines. N Engl J Med. 2006; 354:1109–1112. doi:10.1056/NEJMp058305.
- Herrero R, Quint W, Hildesheim A, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8:e68329. doi:10.1371/journal.pone.0068329.
- Elbasha EH, Dasbach EJ. Impact of vaccinating boys and men against HPV in the United States. Vaccine. 2010; 28:6858–6867. doi:10.1016/j.vaccine.2010.08.030.
- Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States. MMWR Morb Mortal Wkly Rep. 2016;65:850–858. doi:10.15585/mmwr.mm6533a4.
- Cartmell KB, Young-Pierce J, McGue S, et al. Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action. Papillomavirus Research. 2018; 5:21–31. doi:10.1016/j.pvr.2017.11.003.
- Barnard M, George P, Perryman ML, et al. Human papillomavirus (HPV) vaccine knowledge attitudes, and uptake in college students: implications from the Precaution Adoption Process Model. PLoS One. 2017;12(8):e0182266. doi:10.1371/journal.pone.0182266.
- Lee HY, Lust K, Vang S, et al. Male undergraduates’ HPV vaccination behavior: implications for achieving HPV-associated cancer equity. J Community Health.. 2018; 43 :459–466. doi:10.1007/s10900-018-0482-4.
- McRee AL, Katz ML, Paskett ED, et al. HPV vaccination among lesbian and bisexual women: findings from a national survey of young adults. Vaccine. 2014;32(37):4736–4742. doi:10.1016/j.vaccine.2014.07.001.
- The Centers for Disease Control and Prevention. 2017. Adolescent Human Papillomavirus (HPV) Vaccine Coverage Report. National Center for Immunization and Respiratory Diseases. https://www.cdc.gov/vaccines/imzmanagers/coverage/teenvaxview/data-reports/hpv/reports/2017.html. Updated July 26, 2018. Accessed January 13, 2019.
- The Centers for Disease Control and Prevention. 2008. Adolescent Human Papillomavirus (HPV) Vaccination Coverage Report. https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/hpv/reports/2008.html. Updated July 26, 2018. Accessed January 13, 2019.
- The Centers for Disease Control and Prevention. Estimated Vaccination Coverage of Three Dose HPV Series Completion Among Adolescents Aged 13–17 Years by Race/Ethnicity and by State and Selected Area. National Immunization Survey – Teen, United States. https://www.cdc.gov/vaccines/imzmanagers/coverage/nis/teen/tables/13/tab16_HPV3Completion_race_2013.pdf. Updated 2013. Accessed January 13 2019.
- The Centers for Disease Control and Prevention. HPV (Human Papillomavirus) VIS. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv.html. Updated December 12, 2016. Accessed January 19, 2019.
- U.S. Food and Drug Administration. FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 Through 45 Years Old. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm622715.htm Published October 5, 2018. Accessed January 19, 2019.
- Kasymova S, Harrison SE, Pascal C. Knowledge and Awareness of Human Papillomavirus Among College Students in South Carolina. Infect Dis (Auckl). 2019; 12:doi:10.1178633718825077
- Pierre-Victor D, Page TF, Trepka MJ, et al. Impact of Virginia's school-entry vaccine mandate on human papillomavirus vaccination among 13–17-year-old females. Journal of Women’s Health. 2017;26(3):266–275.
- Lefkowitz ES, Kelly KM, Vasilenko SA, et al. Correlates of human papillomavirus vaccination among female university students. Women Health. 2014;54(6):487–501. doi:10.1080/03630242.2014.903552.
- Ratanasiripong NT. Factors related to human papillomavirus (HPV) vaccination in college Men. Public Health Nurs. 2015; 32:645–653. doi:10.1111/phn.12198.
- Strohl AE, Mendoza G, Ghant MS, et al. Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women. Am J Obstet Gynecol. 2015;212(1):65.e1–5. doi:10.1016/j.ajog.2014.06.059.
- Richman AR, Haithcox-Dennis MJ, Allsbrook AR. Feasibility of a catch-up HPV vaccination program among college students attending a large rural university in the south. American Journal of Sexuality Education. 2012;7(3):237–252. doi:10.1080/15546128.2012.707084.
- Jones G, Perez S, Huta Z, et al. The role of human papillomavirus (HPV)-related stigma on HPV vaccine decision-making among college males. Journal of American College Health. 2016;64(7):545–554. doi:10.1080/07448481.2016.1192542.